Strategies for method comparison when changes in the immunogenicity method are needed within a clinical program

Johanna R Mora1, Joleen T White2, Shannon D Chilewski1

  • 1Bioanalytical Sciences, Bristol-Myers Squibb, Princeton, NJ, USA.

Bioanalysis
|April 29, 2020
PubMed

Related Concept Videos